Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive versus conventional insulin therapy for inpatient medical patients
ISRCTN55845280Phase 4Completed
- Sponsor
- National Fund for Research and Development in Health
- Start
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of insulin glargine, insulin isophane and human insulin in hyperglycemia (3 arms), sponsored by National Fund for Research and Development in Health. Primary endpoint: Number of blood glucose measurements between 70 and 130 mg/dL. Started Mar 2009; status: completed.
02
Drugs
insulin glargineinsulin isophanehuman insulin
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on ISRCTN55845280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN55845280.